QQ客服 官方微博 反馈留言

	CTLA4 tagging polymorphisms and risk of colorectal cancer: a case-control study involving 2,306 subjects
	Zou, Chen[1]; Qiu, Hao[2]; Tang, Weifeng[3]; Wang, Yafeng[4]; Lan, Bin[5]; Chen, Yu[6]
刊名	ONCOTARGETS AND THERAPY
	2018
卷号	11页码:4609-4619
关键词	polymorphism immune CTLA-4 tagging colorectal cancer susceptibility
ISSN号	1178-6930
DOI	http://dx.doi.org/10.2147/OTT.S173421
URL标识	查看原文
收录类别	SCI(E) ; PUBMED
WOS记录号	WOS:000441181300001
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5333497
专题	江苏大学
作者单位	1.[1]Jiangsu Univ, Affiliated Peoples Hosp, Dept Gen Surg, Zhenjiang, Jiangsu, Peoples R China. 2.[2]Jiangsu Univ, Sch Med, Dept Immunol, Zhenjiang, Jiangsu, Peoples R China. 3.[3]Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Jiangsu, Peoples R China. 4.[4]Peoples Hosp Xishuangbanna Dai Autonomous Prefect, Dept Cardiol, Jinghong, Yunnan, Peoples R China. 5.[5]Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, 800 Dong Chuan Rd, Shanghai 200240, Peoples R China. 6.[6]Fujian Canc Hosp, Canc Bioimmunotherapy Ctr, Fuzhou, Fujian, Peoples R China.,Fujian Med Univ Canc Hosp, Fuzhou, Fujian, Peoples R China.,Fujian Prov Key Lab Translat Canc Med, Fuzhou, Fujian, Peoples R China.,Fujian Canc Hosp, Dept Med Oncol, Fuzhou, Fujian, Peoples R China.
推荐引用方式 GB/T 7714	Zou, Chen[1],Qiu, Hao[2],Tang, Weifeng[3],et al. CTLA4 tagging polymorphisms and risk of colorectal cancer: a case-control study involving 2,306 subjects[J]. ONCOTARGETS AND THERAPY,2018,11:4609-4619.
APA	Zou, Chen[1],Qiu, Hao[2],Tang, Weifeng[3],Wang, Yafeng[4],Lan, Bin[5],&Chen, Yu[6].(2018).CTLA4 tagging polymorphisms and risk of colorectal cancer: a case-control study involving 2,306 subjects.ONCOTARGETS AND THERAPY,11,4609-4619.
MLA	Zou, Chen[1],et al."CTLA4 tagging polymorphisms and risk of colorectal cancer: a case-control study involving 2,306 subjects".ONCOTARGETS AND THERAPY 11(2018):4609-4619.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。